Supernus Pharmaceuticals
SUPN
#5129
Rank
โ‚น161.70 B
Marketcap
โ‚น2,777
Share price
1.78%
Change (1 day)
-30.52%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: โ‚น161.70 Billion

As of November 2026 Supernus Pharmaceuticals has a market cap of โ‚น161.70 Billion. This makes Supernus Pharmaceuticals the world's 5129th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น161.70 B-39.08%
2025โ‚น265.44 B50.72%
2024โ‚น176.12 B33.81%
2023โ‚น131.62 B-17.51%
2022โ‚น159.56 B38.24%
2021โ‚น115.42 B18.65%
2020โ‚น97.28 B9.48%
2019โ‚น88.85 B-26.88%
2018โ‚น121.52 B-6.83%
2017โ‚น130.43 B53.45%
2016โ‚น85.00 B94.21%
2015โ‚น43.76 B93.61%
2014โ‚น22.60 B21.37%
2013โ‚น18.62 B54.93%
2012โ‚น12.02 B

End of Day market cap according to different sources

On Nov 17th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

โ‚น563.59 Billion
by Nasdaq info icon info icon
โ‚น161.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น61.860 T 38,155.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น16.876 T 10,336.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น115.420 T 71,277.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.428 T 6,967.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚น140.16 B-13.32%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚น2.283 T 1,311.84%๐Ÿ‡บ๐Ÿ‡ธ USA